MetLife, Inc.

New York Stock Exchange
Somewhat Bearish -25

MetLife (NYSE:MET) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings

📉 MetLife's Q1 CY2026 revenue came in at $19.07 billion, representing a 1.3% year-over-year increase but missing Wall Street estimates by 1.7%.

💰 Non-GAAP profit per share reached $2.42, surpassing analyst consensus estimates by 6.6%.

📜 Net Premiums Earned totaled $12.12 billion, beating expectations with a 4% positive variance despite a year-on-year decline of 6.4%.

💵 Pre-tax profit for the quarter was $1.51 billion, maintaining a pre-tax margin of 7.9%.

📉 Book Value Per Share (BVPS) declined 35% from consensus estimates at $37.92 versus an expected $58.37.

🏛️ Founded in 1868, MetLife is a global financial services company offering insurance, annuities, benefits, and asset management services.

💵 Over the last five years, the company experienced sluggish revenue growth with a compounded annual rate of 3.2%.

📈 Recent two-year annualized revenue growth improved to 4.4%, indicating a stronger recent trend compared to the long-term average.

🎯 Net premiums earned account for 69.1% of total revenue, identifying insurance operations as the primary business driver.

⚠️ The stock remained flat at $80.22 immediately after the earnings report due to mixed results on key metrics.

📊 Book value reflects long-term capital growth and is considered a crucial metric for assessing insurer business quality.

📉 BVPS has seen an annual decline of 12.7% over the past five years, though the recent two-year pace slowed to 2.5%.

🔮 Consensus estimates project a potential 70.3% growth in BVPS over the next 12 months to reach $58.37.

🤖 Analysts view investment and fee income as more volatile than core insurance operations, focusing heavily on premium growth.

⚠️ The quarter was characterized as weaker overall because revenue and book value missed targets despite EPS beats.

Bullish Signals
  • MetLife's non-GAAP profit of $2.42 per share beat analysts' consensus estimates by 6.6%.
  • Adjusted EPS reached $2.42, surpassing analyst expectations of $2.27.
  • Net premiums earned of $12.12 billion exceeded the analyst estimate of $11.65 billion.
  • MetLife's annualized revenue growth accelerated to 4.4% over the last two years, which is above its five-year trend.
  • Consensus estimates project MetLife's Book Value per Share (BVPS) to grow by an elite 70.3% over the next 12 months to $58.37.
  • MetLife provides insurance, annuities, employee benefits, and asset management services to a global client base.
Risk Factors
  • MetLife's revenue fell short of Wall Street estimates at $19.07 billion, missing the consensus by $0.34 billion and growing only 1.3% year-over-year.
  • Book Value Per Share (BVPS) suffered a significant miss against analyst expectations of $58.37, closing at $37.92 due to a 7.1% decline year-over-year that significantly trailed the projected growth.
  • The core insurance business is lagging with Net Premiums Earned declining 4% year-on-year, raising concerns about the company's ability to grow its primary revenue stream.
  • Over the past five years, MetLife's compounded annual revenue growth rate was merely 3.2%, which fell short of the broader insurance sector benchmark.
  • The company's long-term BVPS has eroded at a 12.7% annual clip over the last five years, indicating persistent challenges in capital growth despite recent recovery.
Full Analysis
MetLife reported Q1 CY2026 earnings with mixed results relative to analyst expectations, driven primarily by a miss in revenue and book value per share despite a profit beat. The company's non-GAAP profit of $2.42 per share exceeded the consensus estimate of $2.27, representing a 6.6% upside. However, total revenue came in at $19.07 billion, falling short of the estimated $19.41 billion and growing only 1.3% year over year compared to analyst forecasts. Net premiums earned totaled $12.12 billion, slightly beating estimates at $11.65 billion, yet this segment saw a 6.4% year-over-year decline. Consequently, the stock price remained flat at $80.22 immediately following the announcement. Key financial metrics highlighted significant divergence between earnings and balance sheet performance. Pre-tax profit stood at $1.51 billion with a 7.9% margin, while book value per share dropped to $37.92, missing analyst estimates of $58.37 by 35% and marking a 7.1% year-over-year decline. Management noted that quarters not explicitly detailed in the report were outliers affected by outsized investment gains or losses, which can distort recurring fundamentals. The company's five-year compounded annual revenue growth rate has been sluggish at 3.2%, though performance improved to 4.4% annually over the last two years. Analyst commentary emphasizes that while earnings per share and premiums earned are crucial for gauging business health, book value per share is a critical indicator of long-term capital growth that is harder to manipulate than EPS. The report notes that Net Premiums Earned accounted for 69.1% of total revenue over the last five years, establishing it as the primary revenue driver. Looking ahead, consensus estimates project a substantial 70.3% increase in book value per share to $58.37 over the next 12 months. However, the company's historical trajectory shows a 12.7% annual decline in book value over the last five years, with a slower 2.5% annual drop over the most recent two-year period before the current reported figures. The overall assessment characterizes the quarter as weaker due to the revenue miss and significant underperformance in book value relative to expectations.